Snowflake Builds AI Turnaround Case Amid Evolving Data Landscape Bitcoin Prices Decline Thursday Morning Extending Downward Trend MENA Leaders at Baku Forum Redefine Housing Policy Beyond Construction Barclays Reports 18 Profit Rise Raises FullYear Income Guidance JPMorgans Summer Reading List for Wealthy Clients Highlights AI Leadership and Resilience Political Turmoil in Education Sector Cockroach Janta Party Loses Social Media Access Amid NEET Protest Campaign CNF Q4 2023 Earnings Massive EPS Surprise of 54356 Drives Investor Attention Despite Stock Decline National Vision Holdings EYE Q1 2026 Earnings EPS Surpasses Estimates as Stock Edges Higher Brookfield Corporation BN Q1 2026 Earnings EPS Beats Estimates Amid Steady Operational Execution Tesla Q1 2026 Earnings EPS Beats Estimates as Margins Hold Steady KNTK Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions IGC Q1 2026 Earnings EPS Surpasses Estimates by 1416 Amid Revenue Challenges LB Foster FSTR Surges Over 3 as Infrastructure Demand Drives Momentum Coherus Oncology Inc CHRS Rises 255 Key Levels to Watch After Support Hold Hingham Institution for Savings HIFS Edges Higher as Stock Holds Above Key Support Markel Group MKL Edges Higher as Insurer Holds Support Above 1764 Phio Pharmaceuticals PHIO Holds Steady at 109 as Stock Consolidates Between Key Levels AntiBeta ETFs A Potential Shield as Growth Stocks Face Headwinds OSBC Q1 2026 Earnings EPS Misses Estimates as Shares Edge Higher Community West Bancshares CWBC Edges Higher Amid Steady Support Levels Southern Company Junior Subordinated Notes SOJE Dip Slightly as FixedIncome Market Consolidates PureCycle Technologies Unit PCTTU Holds Steady at 620 as Traders Eye Key Support and Resistance Levels ColgatePalmolive CL Edges Higher as Defensive Appeal Strengthens Gorilla Technology Group Inc GRRR Capitalizes on Recent Momentum Approaches Key Resistance Alphabet Inc GOOG Edges Higher as Market Digests Sector Dynamics PhenixFIN Corporation PFX Holds Steady at 4450 as Key Support and Resistance Levels Come into Focus Fulcrum Therapeutics FULC Edges Higher as Biotech Sentiment Stabilizes